Author

Heike Oberwinkler

Heidelberg University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Maria R. SteinkeiD· 2 shared Alexander KlegeriD· 1 shared Eszter Tanner-Matiz· 1 shared Giorgio FoisiD· 1 shared Helen Hilpert· 1 shared Jan LawrenziD· 1 shared Jan MünchiD· 1 shared Jessica LindenmayeriD· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Maria R. SteinkeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tonic interferons defend against respiratory viruses in primary human lung organoid-derived air-liquid interface cultures

Rinu Sivarajan, Paul C. Kirchgatterer, Jan Lawrenz, Eszter Tanner-Matiz, Jessica Lindenmayer, Verena Renz, Tapan Joshi, Heike Oberwinkler, Thorsten Walles, Giorgio Fois, Alexander Kleger, Manfred Frick, Jan Münch, Moritz M. Gaidt, Maria R. Steinke, Konstantin M. J. Sparrer

The paper demonstrates that tonic interferons are critical for early antiviral defense in human lung organoid-derived air-liquid interface cultures against HRV16.

bioRxiv · Dec 11, 2025 · PreprintMicrobiology

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2

Melissa Zimniak, Luisa Kirschner, Helen Hilpert, Nina Geiger, Olga Danov, Heike Oberwinkler, Maria R. Steinke, Katherina Sewald, Jürgen Seibel, Jochen Bodem

The paper screens approved drugs for SARS-CoV-2 inhibition and finds Fluoxetine significantly inhibits the virus at low concentrations, with no effect on other viruses.

Scientific Reports · Mar 15, 2021Peer-reviewedMolecular Biology